Sekar Kathiresan - 04 Dec 2024 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
Chief Executive Officer, Director
Signature
/s/ Andrew Ashe, as Attorney-in-Fact for Sekar Kathiresan
Issuer symbol
VERV
Transactions as of
04 Dec 2024
Net transactions value
$0
Form type
4
Filing time
04 Dec 2024, 16:30:05 UTC
Previous filing
02 Jul 2024
Next filing
10 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERV Common Stock Gift $0 -30,000 -8.5% $0.000000 323,508 04 Dec 2024 Direct F1, F2
transaction VERV Common Stock Gift $0 +30,000 +37% $0.000000 110,997 04 Dec 2024 Sekar Kathiresan 2021 Irrevocable Trust F1
holding VERV Common Stock 240,997 04 Dec 2024 Kathiresan Family 2021 Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 4, 2024, the reporting person transferred 30,000 shares of Verve Therapeutics, Inc. (the "Company") common stock to a family trust. Members of the reporting person's immediate family are the beneficiaries of the trust.
F2 Includes 2,380 shares of the Company's common stock acquired under the Verve Therapeutics, Inc. Amended and Restated 2021 Employee Stock Purchase Plan.